High F-18 FDG uptake in bone marrow by cytokines secreting ectopic mucoepidermoid carcinoma

Clinical Nuclear Medicine

Volumn 34, Issue 11, 2009, Pages 823-824

  Balink, Hans ^a   Nabers, Hans ^a   Kibbelaar, Robby E ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Bone marrow uptake; Cytokines; F18 FDG; Mucoepidermoid carcinoma

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRANSFORMING GROWTH FACTOR BETA1; CYTOKINE;

ADENOSQUAMOUS CARCINOMA; ADULT; AIRWAY OBSTRUCTION; ARTICLE; BONE MARROW; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; CYTOKINE RELEASE; FEMALE; HOARSENESS; HUMAN; HUMAN TISSUE; LUNG CARCINOMA; LUNG LOBECTOMY; OBSTRUCTION PNEUMONIA; POSITRON EMISSION TOMOGRAPHY; PROTEIN BLOOD LEVEL; BRONCHUS TUMOR; MIDDLE AGED; RADIOGRAPHY; SCINTISCANNING; SECRETION;

BONE MARROW; BRONCHIAL NEOPLASMS; CARCINOMA, MUCOEPIDERMOID; CYTOKINES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 73449128723     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3181b81cbd     Document Type: Article

References (11)

1. Pinkston JA, Cole P. Incidence rates of salivary gland tumors: results from a population-based study. Otolaryngol Head Neck Surg. 1999;120:834-840.
2. Williams JD, Agrawal A, Wakely PE Jr. Mucoepidermoid carcinoma of the lacrimal sac. Ann Diagn Pathol. 2003;7:31-34.
3. Shilo K, Foss RD, Franks TJ, et al. Pulmonary mucoepidermoid carcinoma with prominent tumor-associated lymphoid proliferation. Am J Surg Pathol. 2005;29:407-411.
4. Minagawa A, Iitaka M, Suzuki M, et al. A case of primary mucoepidermoid carcinoma of the thyroid: molecular evidence of its origin. Clin Endocrinol (Oxf). 2002;57:551-556.
5. Van de Wiele C, VandeVyver F, Debruyne C, et al. FDG uptake by the bone marrow in NSCLC patients is related to TGF-beta but not to VEGF or G-CSF serum levels. Eur J Nucl Med Mol Imaging. 2008;35:519-522.
6. Dillard DG, Muller S, Cohen C, et al. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II. Arch Otolaryngol Head Neck Surg. 2001;127: 683-686.
7. Aflalo-Hazan V, Gutman F, Kerrou K, et al. Increased FDG uptake by bone marrow in major beta-thalassemia. Clin Nucl Med. 2005;30:754-755.
8. Inoue K, Okada K, Harigae H, et al. Diffuse bone marrow uptake on F-18 FDG PET in patients with myelodysplastic syndromes. Clin Nucl Med. 2006;31:721-723.
9. Quarles van Ufford HM, de Jong JA, Baarslag HJ, et al. F-18 FDG PET in a patient with polycythemia vera. Clin Nucl Med. 2008;33:780-781.
10. Takalkar A, Yu JQ, Kumar R, et al. Diffuse bone marrow accumulation of FDG in a patient with chronic myeloid leukemia mimics hematopoietic cytokine-mediated FDG uptake on positron emission tomography. Clin Nucl Med. 2004;29:637-639.
11. Takahashi S, Kuwabara K, Sawafuji M, et al. F-18 FDG PET imaging in a patient with granulocyte colony stimulating factor producing pulmonary pleomorphic carcinoma. Clin Nucl Med. 2008;33:555-557.